John J. Orloff

CIK: 0001643941

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZBIO

Zenas BioPharma, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

ZBIO
Zenas BioPharma, Inc.
Jun 15, 2026
Award(A)
Stock Option (Right to Buy)
Direct
18.5K shares-
ZBIO
Zenas BioPharma, Inc.
Jun 10, 2025
Award(A)
Stock Option (Right to Buy)
Direct
18.5K shares-
ZBIO
Zenas BioPharma, Inc.
Sep 12, 2024
Award(A)
Stock Option (Right to Buy)
Direct
18.5K shares-

		Type	Shares	Price		Ownership
Jun 15, 2026	ZBIO Zenas BioPharma, Inc.	Award(A) Stock Option (Right to Buy)	18,500	-	-	Direct
Jun 10, 2025	ZBIO Zenas BioPharma, Inc.	Award(A) Stock Option (Right to Buy)	18,500	-	-	Direct
Sep 12, 2024	ZBIO Zenas BioPharma, Inc.	Award(A) Stock Option (Right to Buy)	18,500	-	-	Direct

1-3 of 3 transactions

About ORLOFF JOHN J

ORLOFF JOHN J (SEC CIK 0001643941) files insider reports with the SEC as Director of Zenas BioPharma, Inc. (ZBIO).

Signal8 holds 4 ownership filings by ORLOFF JOHN J (1 Form 3, 3 Form 4), filed between Sep 12, 2024 and Jun 17, 2026. Those filings report 3 transactions, from Sep 12, 2024 to Jun 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on ORLOFF JOHN J's filings is in WALTHAM, MA.

Recent filings by ORLOFF JOHN J

Jun 15, 2026: Grant or award of ZBIO derivative securities (Form 4, code A).
Jun 10, 2025: Grant or award of ZBIO derivative securities (Form 4, code A).
Sep 12, 2024: Grant or award of ZBIO derivative securities (Form 4, code A).

Other insiders filing for Zenas BioPharma, Inc. (ZBIO)

How to read Form 4 transaction codes